2026-01-11 00:00 United States Policy & Regulation Regulatory Approval Translated from EN

Alphatec Spine's SafeOp 3 Neural Monitoring System Clears FDA 510(k)

Summary Alphatec Spine's SafeOp 3 neural monitoring system received FDA 510(k) clearance on January 11, 2026 for intraoperative neural monitoring. The device is regulated as a Class II "Stimulator, Electrical, Evoked Response" under regulation number 882.1870, and the clearance came through the traditional 510(k) pathway, with the FDA finding the device substantially equivalent to a predicate device. Alphatec Spine, a maker of spinal surgery devices and technologies, adds SafeOp 3 to its neural monitoring portfolio; the system is intended to let surgeons assess nerve function in real time during procedures and lower the risk of nerve injury.

Why it matters Intraoperative neuromonitoring is the reimbursed, high-volume end of neural signal recording, and clearances like this are a reminder that most commercial revenue in the field still comes from the operating room rather than from implanted BCIs.

BCIwiki (bciwiki.com) — Alphatec Spine's SafeOp 3 neural monitoring system received FDA 510(k) clearance on January 11, 2026, with the agency determining substantial equivalence to a predicate device. The clearance was granted via the traditional 510(k) pathway, under the Neurology advisory committee.

According to the FDA database, the device is classified as a Stimulator, Electrical, Evoked Response, Class 2, under regulation number 882.1870. SafeOp 3 is used for intraoperative neural monitoring, allowing surgeons to assess nerve function in real time during procedures, potentially reducing the risk of nerve damage. This clearance adds a new product to Alphatec Spine's neural monitoring portfolio.

Compiled by BCIwiki from public sources

Sources · 1

accessdata.fda.gov 2026-01-11

Clinical Translation United States

Read original ↗

Suggest a correction Revisions · none 中 / EN